Trials / Completed
CompletedNCT02964312
LATERA-OFFICE Study
Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OFFICE) Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 166 (actual)
- Sponsor
- Spirox, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter, nonrandomized, single-arm controlled study to obtain outcomes data in participants with severe to extreme class NOSE scores who are undergoing placement of the Spirox Latera Implant with or without concurrent turbinate reduction procedures in an office setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nasal Implant | Latera implant placed as a standalone procedure or in conjunction with a turbinate reduction procedure in an office setting under local anesthesia. |
Timeline
- Start date
- 2016-11-10
- Primary completion
- 2018-03-21
- Completion
- 2019-08-29
- First posted
- 2016-11-16
- Last updated
- 2020-09-03
- Results posted
- 2019-10-30
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02964312. Inclusion in this directory is not an endorsement.